-The Hindustan Times The Planning Commission on Tuesday admitted of a serious flaw in the National Sample Survey data and national accounts, which led to pegging the poverty line at Rs 28 per capita daily consumption in cities. Plan panel deputy chairperson Montek Singh Ahluwalia said the discrepancy between the consumer survey, on whose basis the poverty number were derived, and national accounts was a serious statistical problem. The commission...

Montek Singh says he is willing to revise poverty estimates on the basis of expert opinion Though the incidence of poverty has come down over five years from 2004-05 to 2009-10, it is a startling fact that inequality has increased, with fewer people controlling income. Union Planning Commission Deputy Chairman Montek Singh Ahluwalia admitted on Tuesday that income distribution was not at the desired level and inequality increased in both rural and...

-PTI Describing the fresh poverty estimates of the Planning Commission as a "dishonest" attempt to conceal reality, CPI(M) today asked Prime Minister Manmohan Singh to shun these figures and urged him not to use these "fraudulent" estimates to deny poor people of their right to BPL cards. In a statement, the party said even the recently released Household Amenities and Assets Census of 2011 shows the extent of poverty in different spheres...

-The Hindustan Times The planning commission has released poverty data based on the 66th round of the National Sample Survey (2009-10) on household consumer expenditure survey. According to the new estimate, number of poor in India were 29.8% in 2009-10, down from 37.2% in 2004-05. The data is based on the daily per capita consumption of Rs 28 in urban cities and Rs 22 in rural areas in 2009-10. The same for June...

India's decision this month to produce Germany-based multinational Bayer's anti-cancer drug Nexavar, in the first use of "compulsory licensing" in South Asia, will save lives but also raises intricate questions. Under the compulsory licensing process, a government can under World Trade Organization (WTO) rules bypass a patent owner's rights after three years and order the manufacture and sale of life-saving medicines at much cheaper cost than by obtaining the medicine from...